All Stories

  1. CRISPR technology for diagnosis and treatment of human brucellosis
  2. CRISPR/Dx-based colorimetric and electrochemical detection systems for POCT applications
  3. CRISPR-based platforms for detecting tumor-associated genetic materials in clinical samples
  4. Pan-cancer methylation analysis of circulating cell-free DNA
  5. Recent Advances in Gene Therapy for Hemophilia
  6. CRISPR/Cas-based personal glucose meters for nucleic acid detection
  7. A radiation toxicity biosensing platform based on radioresistant bacteria modified with dr_0423
  8. Artificial base mismatches-mediated PCR (ABM-PCR) for detecting clinically relevant single-base mutations
  9. Blood cancer therapy with synthetic receptors and CRISPR technology
  10. CRISPR detection of cardiac tumor-associated microRNAs
  11. One-pot isothermal CRISPR/Dx system for specific and sensitive detection of microRNA
  12. Rapid, multiplex, one-pot CRISPR/Dx system for detecting cancer fusion genes
  13. UV radiation enhanced encapsulation of superparamagnetic iron oxide nanoparticles (MNPs) in microparticles derived from tumor repopulating cells
  14. SynNotch-Programmed Macrophages for Cancerous Cell Detection and Sensing
  15. Amplification-free nucleic acids detection with next-generation CRISPR/dx systems
  16. Extended replicative lifespan of primary resting T cells by CRISPR/dCas9-based epigenetic modifiers and transcriptional activators
  17. Next-generation CRISPR technology for genome, epigenome and mitochondrial editing
  18. Development of a baculoviral CRISPR/Cas9 vector system for beta-2-microglobulin knockout in human pluripotent stem cells
  19. Rapid and Amplification-free Nucleic Acid Detection with DNA Substrate-Mediated Autocatalysis of CRISPR/Cas12a
  20. Effects of Different Surface Functionalizations of Silica Nanoparticles on Mesenchymal Stem Cells
  21. Multimodal detection of flap endonuclease 1 activity through CRISPR/Cas12a trans-cleavage of single-strand DNA oligonucleotides
  22. Cellular uptake, tissue penetration, biodistribution, and biosafety of threose nucleic acids: Assessing in vitro and in vivo delivery
  23. PAM-flexible dual base editor-mediated random mutagenesis and self-activation strategies to improve CRISPRa potency
  24. Targeted brain tumor imaging by using discrete biopolymer-coated nanodiamonds across the blood–brain barrier
  25. CRISPR-based transgene knock-in and gene correction
  26. Correction to Penetrating the Blood–Brain Barrier by Self-Assembled 3D DNA Nanocages as Drug Delivery Vehicles for Brain Cancer Therapy
  27. Penetrating the Blood–Brain Barrier by Self-Assembled 3D DNA Nanocages as Drug Delivery Vehicles for Brain Cancer Therapy
  28. Synthetic α-l-Threose Nucleic Acids Targeting BcL-2 Show Gene Silencing and in Vivo Antitumor Activity for Cancer Therapy
  29. The Synergy between CRISPR and Chemical Engineering
  30. Targeted Transgene Activation in the Brain Tissue by Systemic Delivery of Engineered AAV1 Expressing CRISPRa
  31. Diverse CRISPR Applications
  32. In vivo epigenome editing and transcriptional modulation using CRISPR technology
  33. Dual-Function, Cationic, Peptide-Coated Nanodiamond Systems: Facilitating Nuclear-Targeting Delivery for Enhanced Gene Therapy Applications
  34. In vivo genome editing using AAV-CRISPR system
  35. Epigenetic studies using CRISPR technology
  36. Human aging research using CRISPR technology
  37. microRNA research using artificial microRNA sponges
  38. Optimization of baculoviral-TALEN system
  39. Cellular reprogramming using baculoviral-ZFN system
  40. Genetic manipulation of human iPSCs using baculoviral-ZFN system
  41. Genetic manipulation of human iPSCs using baculoviral-TALEN system
  42. Association of adiponectin and resistin gene polymorphisms with metabolic syndrome phenotypes
  43. Epistatic interactions between adiponectin and resistin gene polymorphisms
  44. Association of adiponectin and resistin gene polymorphisms with adipokine levels
  45. Novel adiponectin-resistin and insulin resistance indexes